cortirest oral suspensionCORTIREST   SUSPENSION

Composition: Each 5 ml of suspension contains: Deflazacort 6mg.

Indications: Asthma, rheumatoid arthritis, juvenile chronic arthritis and duchene muscular dystrophy.

Adverse events: Hypothalamo-pitutary adrenal axis suppression, carbohydrate intolerance, cushingoid faces, bone loss, muscle wasting, increased susceptibility to infections, steroid-induced psychosis, increased intraocular pressure, cataract, peptic ulceration, skin atropy, striae, fluid and electrolyte imbalance.

Contraindications: Hypersensitivity to any component of the product, systemic infection, patients receiving live virus immunization.

Precautions: Use with caution in patients with cardiac disease, gastritis, diabetes mellitus, osteoporosis, epilepsy.

Dosage and administration: Doses of deflazacort usually lie in the range of 0.25 to 1.5 mg/kg/day. (For detailed information please write to    WINKEM  HEALTHCARE PVT  LTD ,F – 206, RAJ  NAGAR – II ,PALAM  COLONY,   NEW  DELHI – 110077. E-mail :

© 2021 - Winkem Healthcare P Ltd